Alzheimer’s immunotherapy boosted by AbbVie deal via @FT
https://t.co/jWiiRKf3qS— The Propell Group (@ThePropellGroup) October 24, 2017
Alzheimer’s immunotherapy boosted by AbbVie deal via @FT
https://t.co/jWiiRKf3qS— The Propell Group (@ThePropellGroup) October 24, 2017